Identification of a peptide enhancing mucosal and systematic immune responses against EGFP after oral administration in mice

Molecules and Cells

Volumn 21, Issue 2, 2006, Pages 244-250

  Kim, Sae Hae ^a   Lee, Kyung Yeol ^a   Kim, Ju ^a   Park, Seung Moon ^a   Park, Bong Kyun ^b   Jang, Yong Suk ^a  

^a Chonbuk National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Adjuvant; Ganglioside; Mucosal immunization; Phage display library

Indexed keywords

BINDING PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; GANGLIOSIDE GM1; GLYCYLTRYPTOPHANYLLYSYLGLUTAMYLARGINYLLEUCYLSERYLSERYLTRYPTOPHANYLASPARAGINYLARGINYLPHENYLALANINE; HYBRID PROTEIN; PEPTIDE LIBRARY; POLYPEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG FORMULATION; EX VIVO STUDY; FEEDING; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PEYER PATCH; PHAGE DISPLAY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TH2 CELL;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; FECES; G(M1) GANGLIOSIDE; GREEN FLUORESCENT PROTEINS; IMMUNE SYSTEM; IMMUNITY, MUCOSAL; IMMUNOGLOBULINS; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-4; LIGANDS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; PEYER'S PATCHES; RECOMBINANT FUSION PROTEINS; SPLEEN;

ANIMALIA;

EID: 33646569394     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bae, J. L., Lee, J. G., Kang, T. J., Jang, H. S., Jang, Y. S., et al. (2003) Induction of antigen-specific systemic and mucosal immune responses by feeding animals transgenic plants expressing the antigen. Vaccine 21, 4052-4058.
2. Bergelson, L. D., Bukrinskaya, A. G., Prokazova, N. V., Shaposhnikova, G. I., Kocharov, S. L., et al. (1982) Role of gangliosides in reception of influenza virus. Eur. J. Biochem. 128, 467-474.
3. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
4. Carter, L. L. and Dutton, R. W. (1996) Type 1 and type 2: a fundamental dichotomy for all T cell subsets. Curr. Opin. Immunol. 8, 336-342.
5. Cuadros, C., Lopez-Hernandez, F. J., Dominguez, A. L., McClelland, M., and Lustgarten, J. (2004) Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect. Immun. 72, 2810-2816.
6. Daniels, R. S., Kang, C., Patel, D., Xiang, Z., Douglas, N. W., et al. (2003) An HIV type 1 subtype B founder effect in Korea: gp160 signature patterns infer circulation of CTL-escape strains at the population level. AIDS Res. Hum. Retroviruses 19, 631-641.
7. de, Haan, L., Verweij, W. R., Feil, I. K., Holtrop, M., Hol, W. G., et al. (1998) Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit. Immunology 94, 424-430.
8. Fishman, P. H. (1982) Role of membrane gangliosides in the binding and action of bacterial toxins. J. Membr. Biol. 69, 85-97.
9. Foster, N., Clark, M. A., Jepson, M. A., and Hirst, B. H. (1998) Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine 16, 536-541.
10. Fujihashi, K., Dohi, T., Rennert, P. D., Yamamoto, M., Koga, T., et al. (2001) Peyer's patches are required for oral tolerance to proteins. Proc. Natl. Acad. Sci. USA 98, 3310-3315.
11. Fujihashi, K., Koga, T., van Ginkel, F. E., Hagiwara, Y., and McGhee, J. R. (2002) A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 20, 2431-2438.
12. Gardby, E., Wrammert, J., Schon, K., Ekman, L., Leanderson, T., et al. (2003) Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant. J. Immunol. 170, 55-63.
13. Hino, A., Fukuyama, S., Kataoka, K., Kweon, M.-N., Fujihashi, K., et al. (2005) Nasal IL-12p70 DNA prevents and treats intestinal allergic diarrhea. J. Immunol. 174, 7423-7432.
14. Jang, M. H., Kweon, M. N., Iwatani, K., Yamamoto, M., Terahara, K., et al. (2004) Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. USA 101, 6110-6115.
15. Kang, T. J., Han, S. C., Jang, M. O., Kang, K. H., Jang, Y. S., et al. (2004) Enhanced expression of B-subunit of Escherichia coli heat-labile enterotoxin in tobacco by optimization of coding sequence. Appl. Biochem. Biotechnol. 117, 175-187.
16. Kato, H., Fujihashi, K., Kato, R., Dohi, T., Fujihashi, K., et al. (2003) Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions. Int. Immunol. 15, 145-158.
17. Kawamura, Y. I., Kawashima, R., Shirai, Y., Kato, R., Hamabata, T., et al. (2003) Cholera toxin activates dendritic cells through dependence on GMI-ganglioside which is mediated by NF-kappaB translocation. Eur. J. Immunol. 33, 3205-3212.
18. Kim, A., Noh, Y. W., Kim, K. D., Jang, Y. S., Choe, Y. K., et al. (2004) Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination. Exp. Mol. Med. 36, 428-443.
19. Kurganov, B., Doh, M., and Arispe, N. (2004) Aggregation of liposomes induced by the toxic peptides Alzheimer's Abetas, human amylin and prion (106-126): facilitation by membrane-bound GM1 ganglioside, Peptides 25, 217-232.
20. Markwell, M. A., Svennerholm, L., and Paulson, J. C. (1981) Specific gangliosides function as host cell receptors for Sendai virus. Proc. Natl. Acad. Sci. USA 78, 5406-5410.
21. Matsubara, T., Ishikawa, D., Taki, T., Okahata, Y., and Sato, T. (1999) Selection of ganglioside GM1-binding peptides by using a phage library. FEBS Lett. 456, 253-256.
22. Mattei, V., Garofalo, T., Misasi, R., Circella, A., Manganelli, V., et al. (2004) Prion protein is a component of the multimolecular signaling complex involved in T cell activation. FEBS Lett. 560, 14-18.
23. Merritt, E. A., Sarfaty, S., van den Akker, F., L'Hoir, C., Martial, J. A., et al. (1994) Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Protein Sci. 3, 166-175.
24. Miura, Y., Sasao, Y., Kamihira, M., Sakaki, A., Iijima, S., et al. (2004) Peptides binding to a Gb3 mimic selected from a phage library. Biochim. Biophys. Acta 1673, 131-138.
25. Neutra, M. R., Frey, A., and Kraehenbuhl, J. P. (1996) Epithelial M cells: gateways for mucosal infection and immunization. Cell 86, 345-348.
26. Newton, S. M., Jacob, C. O., and Stocker, B. A. (1989) Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 244, 70-72.
27. Ogushi, K., Wada, A., Niidome, T., Okuda, T., Llanes, R., et al. (2004) Gangliosides act as co-receptors for Salmonella enteritidis FliC and promote FliC induction of human betadefensin-2 expression in Caco-2 cells. J. Biol. Chem. 279, 12213-12219.
28. Okahashi, N., Yamamoto, M., Vancott, J. L., Chatfield, S. N., Roberts, M., et al. (1996) Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect. Immun. 64, 1516-1525.
29. Parronchi, P., De Carli, M., Manetti, R., Simonelli, C., Sampognaro, S., et al. (1992) IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cutolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149, 2977-2983.
30. Sakaue, G., Hiroi, T., Nakagawa, Y., Someya, K., Iwatani, K., et al. (2003) HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses. J. Immunol. 170, 495-502.
31. Shin, S. J., Bae, J. L., Cho, Y. W., Lee, D. Y., Kim, D. H., et al. (2005) Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA. FEMS Immunol. Med. Microbiol. 43, 155-164.
32. Son, Y. O., Lee, K. Y., Choi, K. C., Chung, Y., Kim, J. G., et al. (2004) Inhibitory effects of glycoprotein-120 (G-120) from Ulmus davidiana Nakai on cell growth and activation of matrix metalloproteinases. Mol. Cells 18, 163-170.
33. Spellberg, B. and Edwards, J. E. (2001) Type 1/type 2 immunity in infectious diseases. Clin. Infect. Dis. 32, 76-102.
34. Valdes-Gonzalez, T., Inagawa, J., and Ido, T. (2001) Neuropeptides interact with glycolipid receptors: a surface plasmon resonance study. Peptides 22, 1099-1106.
35. van Ginkel, F. W., Jackson, R. J., Yuki, Y., and McGhee, J. R. (2000) Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J. Immunol. 165, 4778-4782.
36. Verlinde, C. L., Merritt, E. A., Van den Akker, F., Kim, H., Feil, I., et al. (1994) Protein crystallography and infectious disease. Protein Sci. 3, 1670-1686.
37. Wu, H., Goud, G. N., and Sierks, M. R. (1998) Artificial antibodies for affinity chromatography of homologous proteins: application to blood clotting proteins. Biotechnol. Prog. 14, 496-499.
38. Wu, C., Zeng, Z., and Wang, Q. (2001) Experimental study of inhibition of hepatitis B by dual-target antisense RNA. Zhonghua Yi Xue Za Zhi. 81, 605-608.
39. Yamamoto, M., Rennert, P., McGhee, J. R., Kweon, M. N., Yamamoto, S., et al. (2000) Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract. J. Immunol. 164, 5184-5191.